Who We Are
Hanslin is a veterinary biotechnology research company dedicated to advancing animal health through innovation. Founded in 2025, our team of scientists, veterinarians, and biotech experts collaborates to solve pressing challenges in veterinary medicine.”
Our Focus
Our mission is to pioneer transformative biotechnologies that improve animal welfare, enhance diagnostics, and deliver next-generation therapeutics. We focus on solving three critical challenges:
Diagnostic
Precision
We develop and deploy cutting-edge diagnostic tools—from AI-powered analysis to rapid biomarker detection—enabling veterinarians to identify diseases earlier and with unmatched accuracy. Our technologies reduce guesswork and empower data-driven decisions for better patient outcomes.
Therapeutic
Innovation
Beyond treatment, we pioneer targeted therapies designed specifically for veterinary medicine, including regenerative biologics and precision drug delivery systems. Each solution is rigorously tested to address real-world clinical challenges while improving safety and efficacy.
Science with
Integrity
Every breakthrough begins with an ethical foundation. We adhere to the highest global standards of animal welfare in research, prioritize sustainable scientific practices, and maintain full transparency with partners and regulators to ensure enduring trust in our science.